-+ 0.00%
-+ 0.00%
-+ 0.00%

Dyne Therapeutics Q2 EPS $(1.08) Misses $(0.75) Estimate

Benzinga·07/29/2026 21:33:15
Listen to the news
Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.75) by 44 percent. This is a 11.34 percent decrease over losses of $(0.97) per share from the same period last year.